Mesoblast | MSB - Selling And Administration Expenses


Mesoblast reported $85.89M in Selling and Administration Expenses for its fiscal semester ending in June of 2026.





Selling And Administration Expenses Change Date
Avita Medical AUD 19.03M 1.95M Dec/2025
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Pacific Edge NZD 16.75M 2.42M Jun/2026
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026